Glucose monitoring for young adults at risk of DKA
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a real-time glucose monitor (RT-CGM) to help young adults with insulin-treated diabetes recognize dangerously high or fast-changing blood sugars. It may help lower the risk of diabetic ketoacidosis (DKA), a serious complication that can lead to urgent care or hospital stays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 25 years old
- You take insulin (by injections or an insulin pump) and have for more than 12 months
- Your diabetes control is not at goal (high HbA1c) or you had DKA or uncontrolled blood sugar admissions in the last 12 months
- You have not used RT-CGM before (you may have used “flash” glucose monitoring for short periods)
- Your kidney function is not severely reduced (eGFR is 30 or higher)
- You are not pregnant or planning pregnancy, and you are not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor (CGM) that checks your sugar levels day and night without frequent finger pricks. It may help you manage your diabetes better by showing glucose trends and alerts.
This study uses a continuous glucose monitor (a small sensor that tracks blood sugar levels) along with a special drink test to find early signs of diabetes. It may help people who are at risk or have early blood sugar problems get a clearer picture of their health.
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels without fingersticks) helps young adults manage type 2 diabetes better. You will wear the sensor and use a phone app to track your glucose.
This study looks at how a continuous glucose monitor affects diabetic ketoacidosis (DKA) risk. By tracking glucose levels closely, researchers hope to reduce dangerous complications.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study tests a continuous glucose monitor (a small sensor that tracks your blood sugar) for 20 days. It's for people with prediabetes to see how their blood sugar changes throughout the day and potentially help manage their condition.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.